This program aims to provide pharmacists with an overview and literature supporting treatment of liver injury and disease, including drug-induced liver injury (DILI), alcohol-related liver disease, non-alcoholic fatty liver disease (NAFLD).
Shenandoah University Bernard J. Dunn School of Pharmacy is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.
Requirements for CE Credit
No external funding has been obtained for this activity. The speakers have no conflicts of interest to disclose and state that the decisions made for program development were free of the control of a commercial interest.
- Discuss causes of liver injury and disease
- Evaluate evidence behind treatment methods
- Apply evidence to patient scenarios
Carrie Hansen, PharmD
Release Date: May 20, 2020
Credit Expiration Date: May 20, 2023